Although the lipidation of GLP-1 peptides can enhance their binding to albumin, significantly increasing their half-life (this is currently a widely adopted pharmacokinetic enhancement strategy for GLP-1 peptides), lipidation modification is not universally applicable
Most users notice some effect within the first week, but the full appetite-suppressing benefit develops over several weeks as the body adjusts to the compound
You talk about the One True Church idea when speaking about different diets arguing online: theres no nuance, and everyone disagrees
Currently, 30% of Americans interested in weight loss say they do not use a GLP-1 medication because of cost or insurance coverage, as insurers cut back on GLP-1 coverage
NAD+ IV therapy may not be suitable for everyone
Results are theoretically permanent because destroyed fat cells do not regenerate